Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Open-Label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years with Haemophilia A or B with or without Inhibitors

Disease Sites:

Benign Hematologic

Staging:

Phase III

Age Group:

Children

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Walker, Shannon

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

02-27-2023

Trial Type:

Treatment

Protocol ID:

VICCNCBH21108

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available